Tag chemotherapy [at least 200 articles] Export

Recent papers classified by the tag chemotherapy.

	Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysis. [My Copy] The lancet oncology, Vol. 8, No. 5. (May 2007), pp. 411-419. by Patricia Harnden, Mike D. Shelley, Bernadette Coles, John Staffurth, Malcom D. Mason posted to review prostate progression meta_analysis chemotherapy biomarker by misonneh on 2009-11-27 11:04:42 as
	HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials. [My Copy] Journal of the National Cancer Institute, Vol. 100, No. 1. (2 January 2008), pp. 14-20. by Alessandra Gennari, Maria Pia P. Sormani, Paolo Pronzato, et al.Matteo Puntoni, Mariantonietta Colozza, Ulrich Pfeffer, Paolo Bruzzi posted to randomized_controlled_trial pooling meta_anlaysis her2 chemotherapy breast anthracycline by misonneh on 2009-11-27 10:58:52 as
	Five-alpha-reductase Inhibitors for prostate cancer prevention. [My Copy] Cochrane database of systematic reviews (Online), No. 2. (2008) by T. J. Wilt, R. MacDonald, K. Hagerty, P. Schellhammer, B. S. Kramer posted to time_to_event review response prostate prevention meta_analysis chemotherapy biomarker 5-alpha_reductase by misonneh on 2009-11-27 10:46:07 as
	Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 15, No. 4. (15 February 2009), pp. 1417-1427. by Dariush Etemadmoghadam, Anna deFazio, Rameen Beroukhim, et al.Craig Mermel, Joshy George, Gad Getz, Richard Tothill, Aikou Okamoto, Maria B. Raeder, Paul Harnett, Stephen Lade, Lars A. Akslen, Anna V. Tinker, Bianca Locandro, Kathryn Alsop, Yoke-Eng E. Chiew, Nadia Traficante, Sian Fereday, Daryl Johnson, Stephen Fox, William Sellers, Mitsuyoshi Urashima, Helga B. Salvesen, Matthew Meyerson, David Bowtell, AOCS Study Group posted to ovarian_cancer integration gene_expression copy-number chemotherapy by jfr on 2009-11-25 12:44:00 as along with 1 person rdiaz
	Effect of molecular disease subsets on disease-free survival in randomized adjuvant chemotherapy trials for estrogen receptor-positive breast cancer. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, No. 28. (1 October 2008), pp. 4679-4683. by Lajos Pusztai, Kristine Broglio, Fabrice Andre, W. Fraser Symmans, Kenneth R. Hess, Gabriel N. Hortobagyi posted to subtypes er-positive dfs chemotherapy breast_cancer by jfr on 2009-11-25 11:12:07 as
	Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy [My Copy] Nature Genetics, Vol. 41, No. 12. (08 November 2009), pp. 1345-1349. by Colin J. D. Ross, Hagit Katzov-Eckert, Marie-Pierre Dube, et al.Beth Brooks, S. Rod Rassekh, Amina Barhdadi, Yassamin Feroz-Zada, Henk Visscher, Andrew M. K. Brown, Michael J. Rieder, Paul C. Rogers, Michael S. Phillips, Bruce C. Carleton, Michael R. Hayden posted to tpmt pharmacogenetics journal_club comt cisplatin chemotherapy association adr by misonneh on 2009-11-25 07:01:55 as
	Intraarterial Chemotherapy for Brain Tumors by Using a Spatial Dose Fractionation Algorithm and Pulsatile Delivery1 [My Copy] Radiology, Vol. 218, No. 3. (March 2001), pp. 724-732. by Y. Pierre Gobin, Timothy F. Cloughesy, Kira L. Chow, et al.Gary R. Duckwiler, James W. Sayre, Karen Milanese, Fernando ViÃ±uela posted to validation tumor radiology neurology interventional-radiology imaging human gbm chemotherapy brain by jclau on 2009-11-25 01:00:38 as
	Hepatic arterial infusion of chemotherapy: the role of diagnostic and interventional radiology [My Copy] Ann Oncol, Vol. 19, No. 5. (18 December 2007), pp. mdm528-851. by A. Ganeshan, S. Upponi, Lye-quen Hon, D. Warakulle, R. Uberoi posted to imaging review radiology liver interventional-radiology clinical chemotherapy cancer by jclau on 2009-11-24 21:32:16 as along with 1 person losesleep
	DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 15, No. 1. (1 January 2009), pp. 315-323. by Oliver Hartmann, Frédérique Spyratos, Nadia Harbeck, et al.Dimo Dietrich, Anne Fassbender, Manfred Schmitt, Serenella Eppenberger-Castori, Vincent Vuaroqueaux, Florence Lerebours, Katrin Welzel, Sabine Maier, Achim Plum, Stephan Niemann, John A. Foekens, Ralf Lesche, John W. Martens posted to time_to_event survival response neoadjuvant methylation gene_specific_methylation chemotherapy breast by misonneh on 2009-11-24 06:40:38 as
	Breast cancer in young women: effect of chemotherapy on ovarian function, fertility, and birth defects. [My Copy] Journal of the National Cancer Institute. Monographs, No. 16. (1994), pp. 125-129. by B. S. Reichman, K. B. Green posted to tempreg hot_flash chemotherapy by kathleenkokolus on 2009-11-23 18:38:18 as
	Advances in the genetics of glioblastoma: are we reaching critical mass? [My Copy] Nature Reviews Neurology, Vol. 5, No. 8. (14 July 2009), pp. 419-426. by Benjamin Purow, David Schiff posted to unexpected_discoveries review relevant_genetics radiation glioblastoma genetic_lesions gbm critical_mass chemotherapy aberrations by burak on 2009-11-23 06:38:46 as
	Predictive signatures for chemotherapy sensitivity in breast cancer: are they ready for use in the clinic? [My Copy] European journal of cancer (Oxford, England : 1990), Vol. 45, No. 10. (July 2009), pp. 1733-1743. by Hervé Bonnefoi, Craig Underhill, Richard Iggo, David Cameron posted to review gene_expression classification chemotherapy breast_cancer by jfr on 2009-11-20 14:14:30 as
	Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial. [My Copy] The lancet oncology, Vol. 8, No. 12. (December 2007), pp. 1071-1078. by Hervé Bonnefoi, Anil Potti, Mauro Delorenzi, et al.Louis Mauriac, Mario Campone, Michèle Tubiana-Hulin, Thierry Petit, Philippe Rouanet, Jacek Jassem, Emmanuel Blot, Véronique Becette, Pierre Farmer, Sylvie André, Chaitanya R. Acharya, Sayan Mukherjee, David Cameron, Jonas Bergh, Joseph R. Nevins, Richard D. Iggo posted to validation gene_expression classification chemotherapy breast_cancer by jfr on 2009-11-20 13:58:47 as along with 1 person frohike
	CNS complications of radiotherapy and chemotherapy. [My Copy] Lancet, Vol. 374, No. 9701. (7 November 2009), pp. 1639-1651. by Carole Soussain, Damien Ricard, John R. Fike, Jean-Jacques J. Mazeron, Dimitri Psimaras, Jean-Yves Y. Delattre posted to radiotherapy cns chemotherapy by Amazoness on 2009-11-17 07:37:51 as along with 1 person calvin
	Prognostic influence of minimal residual disease detected by flow cytometry and peripheral blood stem cell transplantation by CD34+ selection in childhood advanced neuroblastoma. [My Copy] Pediatric blood & cancer, Vol. 49, No. 7. (December 2007), pp. 952-957. by Jiao-Yang Y. Cai, Yan-Jing J. Tang, Li-Min M. Jiang, Ci Pan, Jing Chen, Jing-Yan Y. Tang posted to tumor_cell survival_methods stem_cell_transplantation separation_system selection_procedure prognosis peripheral_blood_stem_cell_transplantation pbsc mrd monoclonal_antibodies minimal_residual_disease free_survival flow_cytometry five_patients fitc chemotherapy cell_separation cd45 bone_marrow by PEcomStock on 2009-11-14 03:59:39 as
	The role of radiotracer imaging in the diagnosis and management of patients with breast cancer: part 2--response to therapy, other indications, and future directions. [My Copy] Journal of nuclear medicine : official publication, Society of Nuclear Medicine, Vol. 50, No. 5. (May 2009), pp. 738-748. by Jean H. Lee, Eric L. Rosen, David A. Mankoff posted to review pet perspective neoadjuvant kim_ chemotherapy breast by misonneh on 2009-11-10 05:17:50 as
	Recent advances in systemic therapy. Advances in adjuvant systemic chemotherapy of early breast cancer [My Copy] Breast Cancer Research, Vol. 11, No. 2. (19 March 2009), 204. by Sara L. Tarruella, Miguel Martin posted to review chemotherapy breast_cancer by jfr on 2009-11-08 22:49:51 as
	Genomic Grade Index Is Associated With Response to Chemotherapy in Patients With Breast Cancer [My Copy] J Clin Oncol, Vol. 27, No. 19. (1 July 2009), pp. 3185-3191. by Cornelia Liedtke, Christos Hatzis, William F. Symmans, et al.Christine Desmedt, Benjamin Haibe-Kains, Vicente Valero, Henry Kuerer, Gabriel N. Hortobagyi, Martine Piccart-Gebhart, Christos Sotiriou, Lajos Pusztai posted to gene_expression chemotherapy breast_cancer by jfr on 2009-11-08 22:33:09 as
	Adjuvant Chemotherapy for Early-Stage Ovarian Cancer: Review of the Literature [My Copy] J Clin Oncol, Vol. 25, No. 20. (10 July 2007), pp. 2909-2920. by Claes Trope, Janne Kaern posted to chemotherapy by poojamaj on 2009-11-07 21:02:54 as
	Intraperitoneal Chemotherapy for Ovarian Cancer: Overview and Perspective [My Copy] J Clin Oncol, Vol. 25, No. 20. (10 July 2007), pp. 2867-2872. by Gautam Rao, Marta Crispens, Mace L. Rothenberg posted to chemotherapy by poojamaj on 2009-11-07 18:34:55 as
	Dysregulation of bone remodelling by imatinib mesylate [My Copy] Blood (4 November 2009), blood-2009-08-237404. by Kate Vandyke, Stephen Fitter, Andrea L. Dewar, Timothy P. Hughes, Andrew C. W. Zannettino posted to leukemia chemotherapy bone by renatomilani on 2009-11-06 02:01:45 as
	5-methylcytosine--the fifth base of DNA: the fifth wheel on a car or a highly promising diagnostic and therapeutic target in cancer? [My Copy] Disease markers, Vol. 23, No. 1-2. (2007), pp. 1-3. by Martin Widschwendter posted to risk_assessment methylation epigenetics comments chemotherapy biomarker 5mdc by misonneh on 2009-11-04 21:48:18 as
	Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, No. 11. (1 June 2008), pp. 3494-3502. by Heidi Fiegl, Allison Jones, Cornelia Hauser-Kronberger, et al.Georg Hutarew, Roland Reitsamer, Robin L. Jones, Mitch Dowsett, Elisabeth Mueller-Holzner, Gudrun Windbichler, Günter Daxenbichler, Georg Goebel, Christian Ensinger, Ian Jacobs, Martin Widschwendter posted to response prediction pharmacogenetics neurod1 neoadjuvant methylation gene_specific_methylation epigenetics circ_dna chemotherapy breast by misonneh on 2009-11-04 21:21:37 as
	Myeloid leukemia cell differentiation protein (Mcl-1) dependency as a marker for chemotherapy sensitivity [My Copy] SciBX: Science-Business eXchange, Vol. 2, No. 42. (29 October 2009) posted to scibx leukemia chemotherapy by renatomilani on 2009-11-03 02:01:00 as
	Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas. [My Copy] Molecular cancer, Vol. 8 (14 July 2009), 48. by Elizabeth M. Swisher, Rachel M. Gonzalez, Toshiyasu Taniguchi, et al.Rochelle L. Garcia, Tom Walsh, Barbara A. Goff, Piri Welcsh posted to response prognosis ovarian kim_ gene_specific_methylation expression dna_repair chemotherapy by misonneh on 2009-10-29 08:17:46 as
	Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment. [My Copy] Human genetics (8 October 2009) by Cristina Rodriguez-Antona, Alvin Gomez, Maria Karlgren, Sarah C. Sim, Magnus Ingelman-Sundberg posted to review response prediction methylation kim_ epidgenetics chemotherapy by misonneh on 2009-10-29 07:13:34 as
	The effect of genetic variability on drug response in conventional breast cancer treatment. [My Copy] European journal of pharmacology (18 October 2009) by Emilia Wiechec, Lise Lotte L. Hansen posted to review response pharmacogenetics metabolism genetics chemotherapy breast by misonneh on 2009-10-29 07:12:29 as
	MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma [My Copy] N Engl J Med, Vol. 352, No. 10. (10 March 2005), pp. 997-1003. by Monika E. Hegi, Annie-Claire Diserens, Thierry Gorlia, et al.Marie-France Hamou, Nicolas de Tribolet, Michael Weller, Johan M. Kros, Johannes A. Hainfellner, Warren Mason, Luigi Mariani, Jacoline E. C. Bromberg, Peter Hau, Rene O. Mirimanoff, J. Gregory Cairncross, Robert C. Janzer, Roger Stupp posted to temozolomide response prognosis prediction mgmt kim_ glioblastoma gene_specific_methylation epigenetics chemotherapy alkylating_agents by misonneh on 2009-10-29 07:06:02 as along with 2 people srp33 alanvelander
	Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer [My Copy] J Clin Oncol, Vol. 24, No. 34. (1 December 2006), pp. 5381-5387. by Stephen E. Jones, Michael A. Savin, Frankie A. Holmes, et al.Joyce A. O'Shaughnessy, Joanne L. Blum, Svetislava Vukelja, Kristi J. McIntyre, John E. Pippen, James H. Bordelon, Robert Kirby, John Sandbach, William J. Hyman, Pankaj Khandelwal, Angel G. Negron, Donald A. Richards, Stephen P. Anthony, Robert G. Mennel, Kristi A. Boehm, Walter G. Meyer, Lina Asmar posted to chemotherapy breast_cancer by merpublic on 2009-10-27 17:42:29 as
	Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735 [My Copy] J Clin Oncol, Vol. 27, No. 8. (10 March 2009), pp. 1177-1183. by Stephen Jones, Frankie A. Holmes, Joyce O'Shaughnessy, et al.Joanne L. Blum, Svetislava J. Vukelja, Kristi J. McIntyre, John E. Pippen, James H. Bordelon, Robert L. Kirby, John Sandbach, William J. Hyman, Donald A. Richards, Robert G. Mennel, Kristi A. Boehm, Wally G. Meyer, Lina Asmar, Daniel Mackey, Stefan Riedel, Hyman Muss, Michael A. Savin posted to chemotherapy breast_cancer by merpublic on 2009-10-27 17:41:59 as along with 1 person lrust
	Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. [My Copy] Current opinion in infectious diseases, Vol. 21, No. 6. (December 2008), pp. 659-667. by Michael J. Doenhoff, Donato Cioli, Jürg Utzinger posted to schistosomiasis praziquantel of mechanism control chemotherapy africa action by ana_sodero on 2009-10-20 17:12:38 as
	Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. [My Copy] Journal of the National Cancer Institute, Vol. 100, No. 3. (6 February 2008), pp. 207-212. by Giuseppe Viale, Meredith M. Regan, Mauro G. Mastropasqua, et al.Fausto Maffini, Eugenio Maiorano, Marco Colleoni, Karen N. Price, Rastko Golouh, Tiziana Perin, R. W. Brown, Anikó Kovács, Komala Pillay, Christian Ohlschlegel, Barry A. Gusterson, Monica Castiglione-Gertsch, Richard D. Gelber, Aron Goldhirsch, Alan S. Coates, International Breast Cancer Study Group posted to prognosis prediction ki67 hormone chemotherapy breast biomarker by misonneh on 2009-10-19 08:47:32 as
	Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, No. 8. (10 March 2008), pp. 1275-1281. by Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess, et al.Fabrice André, Attila Tordai, Jaime A. Mejia, W. Fraser Symmans, Ana M. Gonzalez-Angulo, Bryan Hennessy, Marjorie Green, Massimo Cristofanilli, Gabriel N. Hortobagyi, Lajos Pusztai posted to survival prognosis prediction neoadjuvant chemotherapy breast biomarker by misonneh on 2009-10-19 08:44:43 as
	Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistance. [My Copy] Breast cancer research and treatment, Vol. 112, No. 3. (9 December 2008), pp. 475-488. by Djuana M. Harvell, Nicole S. Spoelstra, Meenakshi Singh, et al.James L. McManaman, Christina Finlayson, Tzu Phang, Susan Trapp, Lawrence Hunter, Wendy W. Dye, Virginia F. Borges, Anthony Elias, Kathryn B. Horwitz, Jennifer K. Richer posted to resonse resistance neoadjuvant hormone chemotherapy breast biomarker by misonneh on 2009-10-19 08:44:01 as along with 1 person jfr
	Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast. [My Copy] Breast cancer research : BCR, Vol. 10, No. 2. (01 April 2008), R30. by Gunter von Minckwitz, Hans-Peter P. Sinn, Günter Raab, et al.Sibylle Loibl, Jens-Uwe U. Blohmer, Holger Eidtmann, Jörn Hilfrich, Elisabeth Merkle, Christian Jackisch, Serban D. Costa, Angelika Caputo, Manfred Kaufmann, German Breast Group posted to response neoadjuvant dynamic chemotherapy breast biomarker by misonneh on 2009-10-19 08:42:21 as
	The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer. [My Copy] Breast cancer research and treatment, Vol. 116, No. 1. (1 July 2009), pp. 53-68. by Robin L. Jones, Janine Salter, Roger A'Hern, et al.Ash Nerurkar, Marina Parton, Jorge S. Reis-Filho, Ian E. Smith, Mitchell Dowsett posted to prediction neoadjuvant dynamic chemotherapy breast biomarker by misonneh on 2009-10-19 08:39:43 as along with 1 person Zephyrus
	Changes in tumour biological markers during primary systemic chemotherapy (PST). [My Copy] Anticancer research, Vol. 28, No. 3B. (n 2008), pp. 1797-1804. by Hans Neubauer, Christian Gall, Ulrich Vogel, et al.Rene Hornung, Diethelm Wallwiener, Erich Solomayer, Tanja Fehm posted to response dynamic chemotherapy breast biomarker by misonneh on 2009-10-19 08:37:21 as
	Predicting response to neoadjuvant chemotherapy in breast cancer: molecular imaging, systemic biomarkers and the cancer metabolome (Review). [My Copy] Oncology reports, Vol. 20, No. 4. (October 2008), pp. 699-703. by Suebwong Chuthapisith, Jennifer M. Eremin, Oleg Eremin posted to review response neoadjuvant chemotherapy biomarker by misonneh on 2009-10-19 08:34:52 as
	Tumor-infiltrating lymphocytes predict response to neoadjuvant chemotherapy in patients with breast carcinoma. [My Copy] Cancer investigation, Vol. 26, No. 10. (December 2008), pp. 1024-1031. by Helena Hornychova, Bohuslav Melichar, Marketa Tomsova, Jindøiska Mergancova, Hana Urminska, Ales Ryska posted to response neoadjuvant immunity chemotherapy breast biomarker by misonneh on 2009-10-19 08:17:43 as
	Stromal matrix protein expression following preoperative systemic therapy in breast cancer. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 15, No. 2. (15 January 2009), pp. 731-739. by Anna-Maria M. Tokes, Attila Marcell M. Szasz, Andrea Farkas, et al.Adrienn Ildiko I. Toth, Magdolna Dank, Laszlo Harsanyi, Bela Akos A. Molnar, Istvan Arthur A. Molnar, Zsolt Laszlo, Zoltan Rusz, Janina Kulka posted to stromal_component response neoadjuvant expression chemotherapy breast by misonneh on 2009-10-19 08:13:43 as
	Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma? [My Copy] The breast journal, Vol. 15, No. 2. (r 2009), pp. 146-154. by Peggy S. Sullivan, Sophia K. Apple posted to response neoadjuvant histology chemotherapy breast by misonneh on 2009-10-19 08:04:25 as
	Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 15, No. 12. (15 June 2009), pp. 4234-4241. by Tomonori Tanei, Koji Morimoto, Kenzo Shimazu, et al.Seung Jin J. Kim, Yoshio Tanji, Tetsuya Taguchi, Yasuhiro Tamaki, Shinzaburo Noguchi posted to response resistance neoadjuvant kim_ expression chemotherapy breast aldh1 by misonneh on 2009-10-19 07:55:29 as
	Mathematical model for G-CSF administration after chemotherapy. [My Copy] Journal of theoretical biology, Vol. 257, No. 1. (7 March 2009), pp. 27-44. by Catherine Foley, Michael C. Mackey posted to hematopoiesis g-csf delay chemotherapy by samubernard on 2009-10-18 19:00:31 as
	A history of cancer chemotherapy. [My Copy] Cancer research, Vol. 68, No. 21. (1 November 2008), pp. 8643-8653. by Vincent T. DeVita, Edward Chu posted to tempreg chemotherapy by kathleenkokolus on 2009-10-16 17:04:49 as along with 3 people tonybradshaw jessopher guhjy
	An Anniversary for Cancer Chemotherapy [My Copy] JAMA, Vol. 296, No. 12. (27 September 2006), pp. 1518-1520. by Jules Hirsch posted to chemotherapy by kathleenkokolus on 2009-10-16 17:00:06 as along with 1 person reyez
	Platinum-based chemotherapy in triple-negative breast cancer [My Copy] Ann Oncol, Vol. 19, No. 11. (1 November 2008), pp. 1847-1852. by B. Sirohi, M. Arnedos, S. Popat, et al.S. Ashley, A. Nerurkar, G. Walsh, S. Johnston, I. E. Smith posted to tnbc platinum chemotherapy brca2 brca1 by merpublic on 2009-10-11 17:42:18 as
	Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer [My Copy] N Engl J Med, Vol. 354, No. 1. (5 January 2006), pp. 34-43. by Deborah K. Armstrong, Brian Bundy, Lari Wenzel, et al.Helen Q. Huang, Rebecca Baergen, Shashikant Lele, Larry J. Copeland, Joan L. Walker, Robert A. Burger, the Gynecologic Oncology Group posted to ovarian oncology obsgyn clinical-trial clinical chemotherapy cancer by jclau on 2009-10-10 17:56:43 as along with 1 person dbs
	Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy. [My Copy] The oncologist, Vol. 13, No. 12. (December 2008), pp. 1235-1245. by Frédérique Penault-Llorca, Catherine Abrial, Inès Raoelfils, et al.Philippe Chollet, Anne Cayre, Marie-Ange A. Mouret-Reynier, Emilie Thivat, Florence Mishellany, Pierre Gimbergues, Xavier Durando posted to response neoadjuvant expression chemotherapy breast biomarker by misonneh on 2009-10-09 08:42:24 as
	Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 27, No. 16. (1 June 2009), pp. 2630-2637. by José Baselga, Vladimir Semiglazov, Peter van Dam, et al.Alexey Manikhas, Meritxell Bellet, José Mayordomo, Mario Campone, Ernst Kubista, Richard Greil, Giulia Bianchi, Jutta Steinseifer, Betty Molloy, Erika Tokaji, Humphrey Gardner, Penny Phillips, Michael Stumm, Heidi A. Lane, J. Michael Dixon, Walter Jonat, Hope S. Rugo posted to response neoadjuvant expression chemotherapy breast by misonneh on 2009-10-09 08:10:36 as
	Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. [My Copy] British journal of cancer, Vol. 92, No. 1. (17 January 2005), pp. 147-155. by R. J. Burcombe, A. Makris, P. I. Richman, et al.F. M. Daley, S. Noble, M. Pittam, D. Wright, S. A. Allen, J. Dove, G. D. Wilson posted to response neoadjuvant expression chemotherapy breast by misonneh on 2009-10-09 08:08:16 as

Note: You may cite this page as: http://www.citeulike.org/tag/chemotherapy

Result page: 1 2 3 4 5 Next

cancer	77
breast	59
review	35
response	30
neoadjuvant	20
biomarker	17
apoptosis	16
thelist	16
survival	14
pharmacogenetics	13
expression	12
lung	12
polysaccharide	11
resistance	11
clinical	10
history	10
psk	9
breast_cancer	8
krestin	8
prognosis	8
progressionfreesurvival	8
prostate	8
sclc	8
superlist	8
treatment-response	8
lungcancer	7
prediction	7
therapy	7
gastric	6
immunotherapy	6
pet	6
radiotherapy	6
randomized	6
tamoxifen	6
treg	6
colon	5
dw-mri	5
epigenetics	5
glioma	5
hormone	5
kim_	5
leukemia	5
nsclc	5
signature	5
treatment	5
brain	4
cancer-crosstalk	4
cat	4
cisplatin	4
drug	4
gene_expression	4
gene_specific_methylation	4
lymphoma	4
mesothelioma	4
methylation	4
moa	4
oncology	4
ph	4
radiation	4
subtypes	4
tumor	4
adjuvant	3
african-american	3
breastcancer	3
classification	3
cocktail	3
comments	3
controlled	3
dna_damage	3
dna_repair	3
dog	3
dynamic	3
gastriccancer	3
gene	3
genetics	3
human	3
imaging	3
integration	3
interaction	3
meta	3
metabolism	3
microarray	3
oral	3
platinum	3
prevention	3
signaling	3
toxicity	3
tumour	3
ultrasound	3
yvonne	3
alkylating_agents	2
biology	2
cervix	2
cpoe	2
drug-discovery	2
interventional-radiology	2
nmr	2
pathways	2
starvation	2
tempreg	2

Tag chemotherapy [at least 200 articles] Export

Related Tags